Reuters logo
BRIEF-Biogen says Nature publishes results from phase 1B study of Aducanumab
2016年8月31日 / 下午5点21分 / 1 年前

BRIEF-Biogen says Nature publishes results from phase 1B study of Aducanumab

Aug 31 (Reuters) - Biogen Inc:

* Nature publishes results from pre-clinical research and phase 1B study of Biogen’s investigational Alzheimer’s disease treatment Aducanumab

* Dose-Dependent reduction of Amyloid- plaque observed in pre-clinical research replicated in phase 1B study in prodromal, mild Alzheimer’s patients

* Dependent slowing of clinical decline Source text for Eikon:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below